Policy considerations that support equitable access to responsible, accountable, safe, and ethical uses of psychedelic medicines

Belouin SJ, Averill LA, Henningfield JE, Xenakis SN, Donato I, Grob CS, Berger A, Magar V, Danforth AL, Anderson BT.

Neuropharmacology. 2022 Nov 15;219:109214.